✦ LIBER ✦

Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon α-2a (40 kDa) plus ribavirin: Impact on health-related quality of life

✍ Scribed by SANJEEV ARORA; CHRISTOPHER O'BRIEN; STEFAN ZEUZEM; MITCHELL L SHIFFMAN; MOISES DIAGO; ALBERT TRAN; PAUL J POCKROS; ROBERT W REINDOLLAR; EDWARD GANE; KAVITA PATEL; NEIL WINTFELD; JESSE GREEN

Book ID: 108950503
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 77 KB
Volume: 21
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2005.04059.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The economics of treating chronic hepati

The economics of treating chronic hepatitis C patients with peginterferon α-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase

✍ J. Hornberger; P. Farci; D. Prati; S. Zeuzem; J. Green; K. K. Patel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Sustained virological response rates and

Sustained virological response rates and health-related quality of life after interferon and ribavirin therapy in patients with chronic hepatitis C virus infection and persistently normal alanine aminotransferase levels

✍ E. J. BINI; S. MEHANDRU 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

The results of a randomized trial lookin

The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon α-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1

✍ C. Brandão; A. Barone; F. Carrilho; A. Silva; M. Patelli; C. Caramori; R. Focacc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB